OK, time to start paying a little attention to $TKMR again...monster, possibly make-or-break month to come.
Well, the Xman only half-way agrees with him. October is a make-or-make month, with very little downside risk at this point in time.
Imagine...we are in possession of the
ONLY effective doses of a life-saving therapy for an epidemic that kills effectively and indiscriminately.
We have one FDA licensed drug being currently sold under the brand-name Marqibo.
https://www.marqibo.com/
We have drugs in human testing that could cure or at least effectively treat
amyloidosis (ALN-TTR02), various cancers (TKM-PLK1), Ebola (TKM-EBOV), Hepatitis B (TKM-HBV), Marburg (TKM-Marburg) or any other virus known-to-man.
We have another development deal with the largest Agricultural Research Company as well (Monsanto).
We are expanding operations to Seattle, Washington and have at least one drug being mysteriously tested in China by Asceltis (ALN-VSP).
Helz belz, I'll toot our horn if Burnaby won't! LOL